CAP-Gly domain: Difference between revisions
added info, ref |
added summary of current pdbs |
||
(One intermediate revision by the same user not shown) | |||
Line 5: | Line 5: | ||
==Activity== | ==Activity== | ||
The cytoskeletal network contains Cytoskeleton-Associated Proteins (CAPs), including CLIP-170 and dynactins, that function in the organization of microtubules and in the transportation of vesicles and organelles. CAPs that bind to the +end of microtubules generally contain one or more glycine-rich domains with a well-conserved GKNDG sequence motif<ref>PMID:8480366</ref>, presumably involved in protein-protein binding. | The cytoskeletal network contains Cytoskeleton-Associated Proteins (CAPs), including CLIP-170 and dynactins, that function in the organization of microtubules and in the transportation of vesicles and organelles. CAPs that bind to the +end of microtubules generally contain one or more glycine-rich domains ("CAP-Gly" domains) with a well-conserved GKNDG sequence motif<ref>PMID:8480366</ref>, presumably involved in protein-protein binding<ref>PMID:1356075</ref>. | ||
==Structure== | ==Structure== | ||
The first crystal structure of a CAP-Gly domain (PDP file [[1lpl]]), from | The first crystal structure of a CAP-Gly domain (PDP file [[1lpl]]), from C. elegans protein F53F4.3, revealed a novel protein fold containing a small 5-strand antiparallel beta-barrel, several loops, and an N-terminal helix. The GKNDG sequence is in two consecutive turns of a surface loop, at one side of a groove (as shown in image at left). The groove is lined by a large, concave patch of residues highly conserved among the related sequences<ref>PMID:12221106</ref>. In the crystal, a dimer is formed by binding of the C-terminus of each chain into the GKNDG groove of the other chain. | ||
[[1tov|1TOV]] is a rebuilt and re-refined version of the same dataset from [[1lpl| 1LPL]], giving an improvement of about 4% in Rfree, identifying a sulfate (seen in both 2D and interactive images), and adding 3 more residues of ordered helix toward the N-terminal end of the domain fragment. Both are from the SouthEast Collaboratory for Structural Genomics (SECSG), solved by single wavelength sulfur-anomalous phasing. The new [[1tov]] structure was produced as part of a systematic 30-structure test of the then-new MolProbity methods for diagnosing and correcting problems in crystallographic models<ref>PMID:15965733</ref>. | [[1tov|1TOV]] is a rebuilt and re-refined version of the same dataset from [[1lpl| 1LPL]], giving an improvement of about 4% in Rfree, identifying a sulfate near the groove (seen in both 2D and interactive images), and adding 3 more residues of ordered helix toward the N-terminal end of the domain fragment. Both are from the SouthEast Collaboratory for Structural Genomics (SECSG), solved by single wavelength sulfur-anomalous phasing. The new [[1tov]] structure was produced as part of a systematic 30-structure test of the then-new MolProbity methods for diagnosing and correcting problems in crystallographic models<ref>PMID:15965733</ref>. | ||
As of 2012 there were 23 CAP-Gly domains in the PDB, including CLIP-170 domain 2 ([[2e3h]]) at 1.45A resolution. | |||
===Crystal structures=== | |||
:[[2e3h]], [[2e3i]] CLIP-170, or restin | |||
:[[1tov]], [[1lpl]] C. elegans hypothetical | |||
:[[1txq]] p150Glued | |||
:[[2hqh]] dynactin/restin | |||
===Solution NMR structures=== | |||
:[[1ixd]], [[1whl]], [[1whm]] domains in human CYLD | |||
:[[1whg]] tubulin-specific chaperone | |||
:[[1whh]], [[2cp0]] CLIPR-59 | |||
:[[1whj]], [[1whk]] domains 1, 3 mouse hypothetical | |||
:[[2cow]] KIF-13B | |||
:[[2coy]] dynactin-1 | |||
:[[2coz]] CAP350 | |||
:[[2cp2]], [[2cp3]] CLIP-115 | |||
:[[2cp5]], [[2cp6]], [[2cp7]] restin | |||
:[[2e4h]] restin/tubulin | |||
==References== | ==References== | ||
<references/> | <references/> |